Sign up to get a first look at Trulicity™!
Eli Lilly Canada is excited to invite you to learn about Trulicity.
Register to attend the presentation live at one of 12 locations across the country. This is your opportunity to ask our experts the questions you have about Trulicity.
If you are not able to attend in person, please register to join us via webcast. Webcast attendees will be able to participate in the Q&A after the presentation online.
Important product information will be presented by Dr. Joanne Lorraine and Dr. Leonardo Mancillas-Adame.
Message from your host
The presentation will include an introduction to Trulicity and will cover:
- Trulicity, the science behind the molecule
- Indications and clinical use for Trulicity
- Overview of pivotal trials and clinical data
- Important safety information for Trulicity
- Introduction to and demonstration of the Trulicity pen
- A live, interactive Q&A on Trulicity with the speakers
The goal of this presentation is to help physicians understand where Trulicity can fit into their practice.
Speaker Information
Dr. Joanne K Lorraine, MD. FRCPC M Ed.
Medical Director, Diabetes Business Unit
Eli Lilly Canada
Dr. Lorraine obtained her medical and internal medicine degrees from the University of Toronto, and then completed a masters degree in medical education while on staff at Sunnybrook Health Sciences Centre. While at Sunnybrook, she was acting head of general internal medicine for several years, as well as Program Director for the Department of Medicine. She then became head of general internal medicine at St Joseph’s Health Centre in Toronto for four years before joining Eli Lilly in 2001.
Upon joining Eli Lilly Canada as a clinical researcher, Dr. Lorraine focussed initially on women’s health issues, especially osteoporosis. In 2006, Dr. Lorraine added the expanding diabetes portfolio to her research work. Currently she is the Medical Director for the Diabetes Business Unit in Canada. She also has responsibilities for global diabetes medical affairs activities, and supports molecules in phase 2 and 3 research.
Dr. Lorraine continues to do clinical work for the Toronto Rehabilitation Hospital in the Cardiac/Metabolic Unit. In her free time, she enjoys practising dressage riding on her Portuguese Lusitano horse.
Dr. Leonardo Mancillas-Adame, MD
Associate Medical Advisor, Diabetes Business Unit
Eli Lilly Canada
Dr. Mancillas-Adame obtained his medical degree from the University of Nuevo Leon, Mexico and his internal medicine and endocrinology degrees as well as the advanced fellowships in Diabetes and Obesity from the National Autonomous University of Mexico. Dr. Mancillas-Adame worked as an attending endocrinologist at the National Institute of Medical Sciences and Nutrition in Mexico City. Before joining Lilly Canada in 2011 as a Clinical Researcher/Advisor, he was the head of the Obesity Clinic at the University of Nuevo Leon university hospital and professor of endocrinology at the same university.
Currently he is leading the Medical Affairs activities for dulaglutide in Canada, and supports phase 3 and 4 clinical research, with a focus on diabetes.
Dr. Mancillas-Adame continues to do academic work in Mexico as an invited professor of the endocrinology and metabolism department at the University of Nuevo Leon.
Trulicity is indicated for the once-weekly treatment of patients with type 2 diabetes mellitus to improve glycemic control, in combination with:
- diet and exercise in patients for whom metformin is inappropriate due to contraindication or intolerance.
- metformin, when diet and exercise plus maximal tolerated dose of metformin do not achieve adequate glycemic control.
- metformin and a sulfonylurea, when diet and exercise plus dual therapy with metformin and a sulfonylurea do not achieve adequate glycemic control.
- prandial insulin with metformin, when diet and exercise plus basal or basal-bolus insulin therapy (up to two injections of basal or basal plus prandial insulin per day) with or without oral antihyperglycemic medications, do not achieve adequate glycemic control.
The product monograph is also available by calling us at 1-888-545-5972.
All Rights Reserved
